This study was performed to assess the efficacy of
alpha-viniferin (
Carex humilis Leyss) on adjuvant-induced
arthritis in rats.
Adjuvant arthritis was induced by a single
subcutaneous injection of 0.1 ml complete
Freund's adjuvant (CFA) containing 7.5 mg Mycobacterium butyricum suspended in 1 ml sterile
paraffin oil into the right hind paw. Forty female Sprague-Dawley rats were injected. Righting reflex was uniformly lost and considered to be the initial point of
arthritis development on day 7 after CFA injection. Rats were divided into four groups, and upon development of
arthritis, tested groups were orally administered 3 or 10 mg/kg
alpha-viniferin or 10 mg/kg
ketoprofen every day for 14 days. The control group was orally administered 2 ml of physiological
saline solution. Bone mineral density (BMD), radiological changes and edematous volumes were measured for 35 days.
Alpha-viniferin suppressed the development of inflammatory
edema, and inhibited the bone destruction, noted with a decrease in BMD (p < 0.05). Hind paw
edema volume, BMD and radiological changes did not differ significantly in the
ketoprofen and
alpha-viniferin groups during the entire study period. In conclusion,
alpha-viniferin suppressed arthritic
inflammation and bony change in rats.